Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

類似資料

• Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
  著者:: Khanna, Dinesh, 等
  出版事項: (2019)
• Efficacy of mycophenolate mofetil and oral cyclophosphamide on skin thickness: post-hoc analyses from the Scleroderma Lung Study I and II
  著者:: Namas, Rajaie, 等
  出版事項: (2018)
• Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II
  著者:: Tashkin, Donald P., 等
  出版事項: (2017)
• Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II
  著者:: Volkmann, Elizabeth R., 等
  出版事項: (2020)
• Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II
  著者:: Goldin, Jonathan G., 等
  出版事項: (2018)